Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: Dominance of HOX dysregulation

Blood

Volumn 102, Issue 1, 2003, Pages 262-268

  Ferrando, Adolfo A ^b   Armstrong, Scott A ^b   Neuberg, Donna S ^b   Sallan, Stephen E ^b   Silverman, Lewis B ^b   Korsmeyer, Stanley J ^b   Look, A Thomas ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CHIMERA; CHROMOSOME 11Q; CLINICAL ARTICLE; CONTROLLED STUDY; FUSION GENE; GENE; GENE EXPRESSION REGULATION; GENE HOX; GENE IDENTIFICATION; GENE MLL; GENE REARRANGEMENT; GENETIC LINKAGE; HUMAN; HUMAN TISSUE; LEUKEMOGENESIS; LEUKEMOID REACTION; MALIGNANT TRANSFORMATION; ONCOGENE; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE;

EID: 0038240453     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-10-3221     Document Type: Article

References (52)

1. Chen C-S, Sorensen PHB, Domer PH, et al. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood. 1993;81:2386-2393.
2. Janssen JW, Ludwig WD, Borkhardt A, et al. Prepre-B acute lymphoblastic leukemia: high frequency of alternatively spliced ALL1-AF4 transcripts and absence of minimal residual disease during complete remission. Blood. 1994;84:3835-3842.
3. Kaneko Y, Shikano T, Maseki N, et al. Clinical characteristics of infant acute leukemia with or without 11q23 translocations. Leukemia. 1988;2: 672-676.
4. Pui C-H, Behm FG, Raimondi SC, et al. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med. 1989; 321:136-142.
5. Super HJG, McCabe NR, Thirman MJ, et al. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood. 1993;81:3705-3711.
6. Ohshima A, Miura I, Chubachi A, et al. 11q23 aberration is an additional chromosomal change in de novo acute leukemia after treatment with etoposide and mitoxantrone. Am J Hematol. 1996; 53:264-266.
7. DiMartino JF, Cleary ML. MLL rearrangements in haematological malignancies: lessons from clinical and biological studies. Br J Haematol. 1999; 106:614-626.
8. Look AT. Oncogenic transcription factors in the human acute leukemias. Science. 1997;278: 1059-1064.
9. Yu BD, Hess JL, Horning SE, Brown GA, Korsmeyer SJ, Altered Hox expression and segmental identity in Mll-mutant mice. Nature. 1995;378: 505-508.
10. Ernst P, Wang J, Korsmeyer SJ. The role of MLL in hematopoiesis and leukemia. Curr Opin Hematol. 2002;9:282-287.
11. Ayton PM, Cleary ML. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene. 2001;20:5695-5707.
12. Armstrong SA, Staunton JE, Silverman LB, et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet. 2002;30:41-47.
13. Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 2002; 1:133-143.
14. Schumacher A, Magnuson T. Murine polycomband trithorax-group genes regulate homeotic pathways and beyond. Trends Genet. 1997;13:167-170.
15. Nakamura T, Largaespada DA, Shaughnessy JD Jr, Jenkins NA, Copeland NG. Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias. Nat Genet. 1996;12:149-153.
16. Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J. 1998;17:3714-3725.
17. Thorsteinsdottir U, Sauvageau G, Hough MR, et al. Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia. Mol Cell Biol. 1997;17:495-505.
18. Milne TA, Briggs SD, Brock HW, et al. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell. 2002;10:1107-1117.
19. Ferrando AA, Neuberg DS, Staunton J, et al. Gene expression signatures define novel oncogenic pathways in T-cell acute lymphoblastic leukemia. Cancer Cell. 2002;1:75-87.
20. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999;286:531-537.
21. Pilarski LM, Turley EA, Shaw AR, et al. FMC46, a cell protrusion-associated leukocyte adhesion molecule-1 epitope on human lymphocytes and thymocytes. J Immunol. 1991;147:136-143.
22. Galy A, Verma S, Barcena A, Spits H. Precursors of CD3+CD4+CD8+ cells in the human thymus are defined by expression of CD34: delineation of early events in human thymic development. J Exp Med. 1993;178:391-401.
23. Ma A, Pena JC, Chang B, et al. Bclx regulates the survival of double-positive thymocytes. Proc Natl Acad Sci U S A. 1995;92:4763-4767.
24. Palker TJ, Fong AM, Scearce RM, Patel DD, Haynes BF. Developmental regulation of lymphocyte-specific protean 1 (LSP1) expression in thymus during human T-cell maturation. Hybridoma. 1998;17:497-507.
25. Akashi K, Kondo M, Weissman IL. Role of interleukin-7 in T-cell development from hematopoietic stem cells. Immunol Rev. 1998;165:13-28.
26. Bonilla FA, Kokron CM, Swinton P, Geha RS. Targeted gene disruption of murine CD7. Int Immunol. 1997;9:1875-1883.
27. Barcena A, Muench MO, Roncarolo MG, Spits H. Tracing the expression of CD7 and other antigens during T- and myeloid-cell differentiation in the human fetal liver and thymus. Leuk Lymphoma. 1995;17:1-11.
28. Pace U, Bockman JM, MacKay BJ, Miller WH Jr, Dmitrovsky E, Goldberg AR. A ribozyme which discriminates in vitro between PML/RAR alpha, the t(15;17)-associated fusion RNA of acute promyelocytic leukemia, and PML and RAR alpha, the transcripts from the nonrearranged alleles. Cancer Res. 1994;54:6365-6369.
29. Blom B, Heemskerk MH, Verschuren MC, et al. Disruption of alpha beta but not of gamma delta T cell development by overexpression of the helixloop-helix protein Id3 in committed T cell progenitors. EMBO J. 1999;18:2793-2802.
30. Kim D, Peng XC, Sun XH. Massive apoptosis of thymocytes in T-cell-deficient Id1 transgenic mice. Mol Cell Biol. 1999;19:8240-8253.
31. Kersey JH, Wang D, Oberto M. Resistance of t(4; 11) (MLL-AF4 fusion gene) leukemias to stress-induced cell death: possible mechanism for extensive extramedullary accumulation of cells and poor prognosis. Leukemia. 1998;12:1561-1564.
32. Rowley JD. The role of chromosome translocations in leukemogenesis. Semin Hematol. 1999; 36:59-72.
33. Dobson CL, Warren AJ, Pannell R, Forster A, Rabbitts TH. Tumorigenesis in mice with a fusion of the leukaemia oncogene mll and the bacterial lacZ gene. EMBO J. 2000;19:843-851.
34. Luo RT, Lavau C, Du C, et al. The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis. Mol Cell Biol. 2001;21:5678-5687.
35. Slany RK, Lavau C, Cleary ML. The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX. Mol Cell Biol. 1998;18:122-129.
36. Ernst P, Wang J, Huang M, Goodman RH, Korsmeyer SJ. MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein. Mol Cell Biol. 2001;21:2249-2258.
37. + subpopulations of human bone marrow cells. Proc Natl Acad Sci U S A. 1994;91:12223-12227.
38. Taketani T, Taki T, Shibuya N, et al. The HOXD11 gene is fused to the NUP98 gene in acute myeloid leukemia with t(2:11)(q31;p15). Cancer Res. 2002;62:33-37.
39. Shimada H, Arai Y, Sekiguchi S, Ishii T, Tanitsu S, Sasaki M. Generation of the NUP98-HOXD13 fusion transcript by a rare translocation, t(2; 11)(q31;p15), in a case of infant leukaemia. Br J Haematol. 2000;110:210-213.
40. Raza-Egilmez SZ, Jani-Sait SN, Grossi M, Higgins MJ, Shows TB, Aplan PD. NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia. Cancer Res. 1998;58:4269-4273.
41. Hunger SP, Galili N, Carroll AJ, Crist WM, Link MP, Cleary ML. The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood. 1991;77:687-693.
42. Nakamura T, Largaespada DA, Lee MP, et al. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat Genet. 1996;12:154-158.
43. Nutt SL, Heavey B, Rolink AG, Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature. 1999; 401:556-562.
44. Cumano A, Paige CJ, Iscove NN, Brady G. Bipotential precursors of B cells and macrophages in murine fetal liver. Nature. 1992;356:612-615.
45. King AG, Kondo M, Scherer DC, Weissman IL. Lineage infidelity in myeloid cells with TCR gene rearrangement: a latent developmental potential of proT cells revealed by ectopic cytokine receptor signaling. Proc Natl Acad Sci U S A. 2002;99: 4508-4513.
46. Armstrong SA, Staunton JE, Mabon ME, et al. The MLL dependent gene expression profile: characterization of a unique leukemia and identification of a potential molecular therapeutic target [abstract]. Blood. 2001;98:800a.
47. Bertho JM, Chapel A, Loilleux S, et al. CD135 (Flk2/Flt3) expression by human thymocytes delineates a possible role of FLT3-ligand in T-cell precursor proliferation and differentiation. Scand J Immunol. 2000;52:53-61.
48. Murre C. Intertwining proteins in thymocyte development and cancer. Nat Immunol. 2000;1:97-98.
49. Miyamoto A, Cui X, Naumovski L, Cleary ML. Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells. Mol Cell Biol. 1996;16:2394-2401.
50. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:1937-1947.
51. Behm FG, Raimondi SC, Frestedt JL, et al. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood. 1996;87: 2870-2877.
52. Rubnitz JE, Camitta BM, Mahmoud H, et al. Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation. J Clin Oncol. 1999;17:191-196.